Journal Am Soc Echocardiography
- Association with Outcome of the Regurgitant-Volume Adjusted Right Ventricular Ejection Fraction in Secondary Tricuspid Regurgitationby Alexandra Clement, Michele Tomaselli, Luigi P. Badano, Diana R. Hadareanu, Noela Radu, Marco Penso, Sergio Caravita, Claudia Baratto, Samantha Fisicaro, Caterina Delcea, Alessandra Rota, Radu Sascau, Denisa Muraru on January 21, 2025 at 12:00 am
In patients with secondary tricuspid regurgitation (STR), right ventricular ejection fraction (RVEF) may not accurately reflect the actual RV systolic performance since a considerable amount of the RV stroke volume (SV) is regurgitated back into the right atrium. To overcome this limitation, we explored the association with the outcome of the effective RVEF (eRVEF), which accounts for the […]
- Diastolic Dysfunction and Survival in Patients with Preserved or Mildly Reduced Left Ventricular Ejection Fraction following Myocardial Infarctionby Nicole Ivy Chan, John J. Atherton, Anish Krishnan, Christopher Hammett, Peter Stewart, Michael Mallouhi, William Vollbon, Liza Thomas, Sandhir B. Prasad on January 17, 2025 at 12:00 am
Left ventricular ejection fraction (LVEF) is relatively indiscriminate for prognosis in patients with preserved or mildly reduced LVEF (>40%) following myocardial infarction (MI). This study sought to determine the value of guideline-based assessment of diastolic dysfunction (DD) in predicting long-term all-cause and cardiac mortality in patients with a first-ever MI and LVEF>40%.
- Association of Impaired Relaxation Mitral Inflow Pattern (Grade 1 Diastolic Function) with Long-term Non-Cardiovascular and Cardiovascular Mortalityby Kathleen A. Young, Richard J. Rodeheffer, Jared G. Bird, William R. Miranda, Horng H. Chen, Jae K. Oh, Garvan C. Kane on January 15, 2025 at 12:00 am
Abnormalities of left ventricular (LV) diastolic function are established independent predictors of heart failure (HF) and mortality.
- Left ventricular elastance with resting volumetric transthoracic echocardiography identifies different phenotypes in heart failure with preserved ejection fraction: A retrospective analysis of a multicenter prospective observational studyby Yi Wang, Quirino Ciampi, Lauro Cortigiani, Angela Zagatina, Ratnasari Padang, Garvan C. Kane, Hector R. Villarraga, Jesus Peteiro Vazquez, Elena Kalinina, Alla Boshchenko, Tamara Ryabova, Fiore Manganelli, Hugo Rodriguez-Zanella, Jelena Celutkiene, Elisa Merli, Clarissa Borguezan-Daros, Jorge Lowenstein, Rosina Arbucci, Diego M. Lowenstein Haber, Sofia Marconi, Pablo M. Merlo, Karina Wierzbowska-Drabik, Ayten Safarova, Tatiana Timofeeva, Ariel Saad, Francesca Bursi, Jaroslaw D. Kasprzak, Ana Djordjevic-Dikic, Sergio Kobal, Dimitrios Soulis, Nicola Gaibazzi, Nithima Chaowalit Ratanasit, Rodolfo Citro, Albert Varga, Marco Fabio Costantino, Fausto Rigo, Aleksandra Nikolic, Giovanni Benfari, Miguel Amor, Ana Cristina Camarozano, Rosangela Cocchia, Attila Palinkas, Antonello D’Andrea, Miodrag Ostojic, Tamara Kovačević Preradović, Iana Simova, Federica Re, Paolo Colonna, Maria Grazia D’Alfonso, Fabio Mori, Claudio Dodi, Filipa Xavier Valente, Giovanni Tripepi, Lixue Yin, Mauro Pepi, Scipione Carerj, Patricia A. Pellikka, Eugenio Picano, Stress echo 2030 study group on January 14, 2025 at 12:00 am
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity including patients with different phenotypes of near normal, normal, and supernormal left ventricular (LV) function.
- Optimal Cut Plane for Tricuspid Annular Plane Systolic Excursion Measurementby Michito Murayama, Sanae Kaga, Hisao Nishino, Yusuke Yanagi, Mana Goto, Fuka Ando, Shinobu Yokoyama, Marina Yamaguchi, Kazunori Okada, Masahiro Nakabachi, Makoto Kambayashi, Yui Shimono, Kosuke Nakamura, Yoji Tamaki, Suguru Ishizaka, Hiroyuki Iwano, Toshiyuki Nagai, Toshihisa Anzai on January 14, 2025 at 12:00 am
- Blood Pressure and Echocardiographic Interpretation – Guideline Revision Neededby Christopher Lee, Theodore P. Abraham, Nelson B. Schiller on January 10, 2025 at 12:00 am
- Establishing dosing parameters for the use of maternal hyperoxygenation to affect fetal cardiovascular physiology
- Reevaluating Normal-Flow Low-Gradient Severe Aortic Stenosis: Clinical Phenotypes and Outcomes in Severe Aortic Stenosis Among TAVR Patientsby Amro Badr, Mustafa Suppah, Kamal Awad, Juan Farina, Bobbi Jo Heon, Rachel Wraith, Bishoy Abraham, Sara Kaldas, Vuyisile Nkomo, Reza Arsanjani, Chieh-Ju Chao, David Holmes, Said Alsidawi on January 6, 2025 at 12:00 am
Aortic stenosis (AS) is a complex condition with various hemodynamic subtypes, each with distinct clinical profiles and outcomes. This study aimed to assess the characteristics and outcomes of different AS phenotypes based on flow and gradient patterns.
- Dapagliflozin and Cardiac Reverse Remodeling: New Insights in the Mechanistic Puzzle of SGLT2 Inhibitorsby Safia Chatur, Timothy W. Churchill on January 6, 2025 at 12:00 am
- Acute maternal hyperoxygenation to predict hypoxia and need for emergency intervention in fetuses with transposition of the great arteries: a pilot studyby Trisha Vigneswaran, Chris Oakley, Hannah R. Bellsham-Revell, Matthew Jones, Vita Zidere, Reza Razavi, John Simpson on January 6, 2025 at 12:00 am
Newborns with transposition of the great arteries (TGA) are at risk of severe hypoxia from inadequate atrial mixing, closure of the arterial duct and/or pulmonary hypertension (PPHN). Acute maternal hyperoxygenation (AMH) might assist in identifying at-risk fetuses. We report pulmonary vasoreactivity to AMH in TGA fetuses and its relationship to early postnatal hypoxia and requirement for […]
- Simplifying the echocardiographic definition of atrial secondary tricuspid regurgitation: when less is moreby Rebecca T. Hahn on January 4, 2025 at 12:00 am
- The Indispensable and Diverse Role of Clinician-Scientists in Echo Innovationby Jonathan R. Lindner, Daniel Forsha, Raymond Stainback on January 1, 2025 at 12:00 am
This last year was sadly punctuated by the death of Alfred “Ned” Weyman, ASE Past President and one of the most impactful physician-scientists in the evolution of echocardiography. In his 1995 Edler lecture, Dr. Weyman expressed concern that the vast majority of cardiovascular imaging science could be categorized as “technology surfing.” This term was defined for the audience as a […]